Mucopolysaccharidosis (MPS) Treatment Market 2021 Key Insights, Demand, Growth

1. Mucopolysaccharidosis (MPS) Treatment Market Analyzed by Top 5 Key Players by Size, Revenue and Forecasts – 2029 | FMI May 2021 Report Id : REP-GB-5880 Published On: Category : Healthcare, Pharmaceuticals & Medical Devices 2019-05-10 www.futuremarketinsights.com I @futuremarketins I /company/future-market-insights © 2019 Future Market Insights, All Rights Reserved www.futuremarketinsights.com I @futuremarketins I /company/future-market-insights © 2019 Future Market Insights, All Rights Reserved

2. About Future Market Insights Future Market Insights (FMI) is a premier provider of syndicated research reports, custom research reports, and consulting services. We deliver a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights,aerial view of the competitive framework,and future market trends. We provide research services at a global as well as regional level; key regions include GCC, ASEAN, and BRIC. Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy, Technology,Healthcare, and Retail. We have a global presence with delivery centers across India specializing in providing global research reports and country research reports. FMI is headquartered out of London, U.K., with a state-of-the-art delivery center located in Pune, India. We combine our knowledge and learning from every corner of the world to distill it to one thing – the perfect solutionfor our client. Research Capabilities Sector Coverage             Customized Research Syndicated Research Investment Research Social Media Research Automotive and Transportation Electronics, Semiconductor, and ICT Retail and Consumer Products Industrial Automation and Equipment Chemicals & Materials Food and Beverages Services and Utilities Energy, Mining, Oil, and Gas Customized Research Subscription Information Syndicated Research For detailed subscription information please contact Hari. T (Sr. Manager - Global Business Development) Investment Research T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268 Social Media Research Email: hari.t@futuremarketinsights.com www.futuremarketinsights.com I @futuremarketins I /company/future-market-insights 2 © 2019 Future Market Insights, All Rights Reserved

3. Research Methodology (1/2) Systematic Research Approach 1 In-depth secondary research is used to ascertain overall market size, top industry players, top products, industry associations, etc. Research & Intelligence Data Collection Data Filter & Analysis Actionable Insights Business Solution Market profiling 2 FMI formulates a detailed discussion guide to conduct expert and industry interviews     Identifying key opinion leaders Questionnaire design In-depth interviews Coverage across value chain Formulating discussion guide 3 A FMI develops a list of industry players (manufacturers), distributors, retailers and industry experts Primary Research       Key industry experts Channel study Developments Market dynamics Products Conclusions Developing list of respondents B 4 FMI conducts interviews with industry experts, industry players, distributors and retailers SOLUTION Desk Research Data collection      Market participants Key strengths Product portfolio Mapping as per value chain Key focus segments C Company Analysis Data is validated by triangulation method, wherein secondary, primary and FMI analysis contribute to the final data 5 Data validation 6 Data is scrutinized using MS-Excel to obtain qualitative and quantitative insights about the industry Data analysis Primary Research# Secondary Research # Paid Publications#           Linkedin Zoominfo Salesforce Avention Company websites Company annual reports White papers Financial reports Factiva GBI Genios Meltwater 7 FMI delivers industry insights and information in the required format (PDF) Insights   # includes sources of databases www.futuremarketinsights.com I @futuremarketins I /company/future-market-insights 3 © 2019 Future Market Insights, All Rights Reserved

4. Mucopolysaccharidosis (MPS) Treatment Market Analysis A market study presented by FMI ' Mucopolysaccharidosis Treatment Market: Global Industry Analysis 2014-2018 and Opportunity Assessment 2019-2029,' explains the significant factors influencing the current market structure. According to research, the mucopolysaccharidosis treatment is still emerging, and different geographies have implemented standard treatment options for the condition. However, there is no universally accepted treatment pattern for mucopolysaccharidosis. Mucopolysaccharidosis falls under rare diseases, which is a complex, diverse, constantly evolving field, and there is a significant shortage of medical and scientific data related to it. Mucopolysaccharidosis treatment and diagnosis involves complex managing requirements, which include long-term care, rehabilitation support, and a continuous treatment plan. Request a Sample Report with Table of Contents and Figures: https://www.futuremarketinsights.com/reports/sample/rep- gb-5880 www.futuremarketinsights.com I @futuremarketins I /company/future-market-insights 4 © 2019 Future Market Insights, All Rights Reserved

5. Mucopolysaccharidosis (MPS) Treatment Market Analysis Research Activities Uplift Stem Cell Therapy Application in MPS Treatment In the present scenario, the drugs that are considered for mucopolysaccharidosis treatment, such as aldurazyme, naglazyme, vimizim, elaprase, mepsevii and hunterase, are the only regulated and recommended drugs present in the market. These drugs fall under enzyme replacement therapies, however, with present research initiatives for stem cell therapies, the latter is considered a prominent mucopolysaccharidosis treatment. Clinical research shows that stem cell transplantation covers a large area that is not covered with the more frequently recommended practice of enzyme replacement therapies, which changes the current market structure for mucopolysaccharidosis treatment, prioritising the latter. Stem cell therapy is a therapeutic option for mucopolysaccharidosis patients suffering from a severe phenotype, as research shows the method can preserve neurocognition or can even help break the progressive neurodegeneration. The method is provided with strict selection criteria, which is followed by maintained regulations. www.futuremarketinsights.com I @futuremarketins I /company/future-market-insights 5 © 2019 Future Market Insights, All Rights Reserved

6. Mucopolysaccharidosis (MPS) Treatment Market Analysis Research shows that stem cell therapy as a treatment option is gaining popularity among healthcare professionals for mucopolysaccharidosis treatment, which can be attributed to the relation of its better reach towards a normal health condition for the patient. Preview Analysis Global Mucopolysaccharidosis (MPS) Treatment Market Segmentation by Treatment Type (Enzyme Replacement Therapies, Stem Cell Therapies, Bone Marrow Transplantation (BMT), Umbilical Cord Blood Transplantation (UCBT), By Type of MPS (MPS I, MPS II, MPS IV A, MPS VI, MPS VII); By End User (Hospital, Specialty Clinics, Medical Research Centers, Home-infusion): https://www.futuremarketinsights.com/reports/mucopolysaccharidosis- treatment-market Enzyme Replacement Therapy Remains Lucrative for Market Investors Click here to Order a free sample As per further assessments of the mucopolysaccharidosis treatment market, it has been difficult to collect epidemiological data pertaining to rare diseases, especially mucopolysaccharidosis treatment, which is likely to impede the actual estimation of the economic burden associated with the condition. www.futuremarketinsights.com I @futuremarketins I /company/future-market-insights 6 © 2019 Future Market Insights, All Rights Reserved

7. Mucopolysaccharidosis (MPS) Treatment Market Analysis The cost estimation for each mucopolysaccharidosis treatment type is affecting and, in turn, creating a more vulnerable situation for the businesses and disrupting research & development activities for each company. Enzyme replacement therapy is the most attractive segment for investors, however, the unavailability of reimbursement plans and precise treatment plans is encouraging most patient in developing regions to opt for symptomatic treatments instead of enzyme replacement therapy, which is still considered to be the standard mucopolysaccharidosis treatment. Our advisory services are aimed at helping you with specific, customized insights that are relevant to your specific challenges. Let us know about your challenges and our trusted advisors will connect with you: https://www.futuremarketinsights.com/askus/rep- gb-5880 www.futuremarketinsights.com I @futuremarketins I /company/future-market-insights 7 © 2019 Future Market Insights, All Rights Reserved

8. Mucopolysaccharidosis (MPS) Treatment Market Analysis Key Players Focus on Clinical Research of Treatment Models The report segments the mucopolysaccharidosis treatment market into seven regions to elaborate on the regional trends pertaining to the treatment plan. Major players are focusing on increasing their market share in the Asia Pacific market through strategic collaborations with regional research institutes. There is a lack of awareness about rare diseases among the general public as well as in medical healthcare facilities in several emerging economies. According to a survey and industry report, it takes patients in the US an average of 7.6 years and patients in the UK an average of 5.6 years to actually receive a proper diagnosis. Moreover, it involves a team of healthcare professionals to actually get the right mucopolysaccharidosis treatment and diagnosis pattern for reported cases. Manufacturers are in the process of introducing a considerable number of mucopolysaccharidosis treatment options, which are currently under clinical trials. An estimated 160 and above clinical trials are being performed for mucopolysaccharidosis treatment. Thus, ensuring that the manufacturers take this mucopolysaccharidosis treatment market to be lucrative and potential rich in terms of revenue. Medical research institutes play an important role in this particular market. www.futuremarketinsights.com I @futuremarketins I /company/future-market-insights 8 © 2019 Future Market Insights, All Rights Reserved

9. Mucopolysaccharidosis (MPS) Treatment Market Analysis They are expected to be the bridge between treatment plans and economical solutions for manufacturers, thus leaving an explicable and lucrative model for mucopolysaccharidosis treatment. The mucopolysaccharidosis treatment market includes companies such as BioMarin Takeda Pharmaceutical Company Limited, Sanofi S.A., and Ultragenyx Pharmaceutical Inc. BioMarin accounts for a significant value share in the present mucopolysaccharidosis treatment market. The currently existing promising drug types are expected to face competition from emerging candidates. In addition the mucopolysaccharidosis treatment products of other companies, such as Sangamo Therapeutics, Inc., REGENXBIO Inc., Sarepta Therapeutics, Abeona Therapeutics, Inc., and others, are also in the pipeline. Buy Mucopolysaccharidosis (MPS) Treatment Market Full Report @ https://www.futuremarketinsights.com/checkout/5880 www.futuremarketinsights.com I @futuremarketins I /company/future-market-insights 9 © 2019 Future Market Insights, All Rights Reserved

10. To know more about us, please visit our website: www.futuremarketinsights.com For sales queries or new topics email us on: sales@futuremarketinsights.com For media queries, contact the press office at press@futuremarketinsights.com For other queries contact: Hari. T (Sr. Manager - Global Business Development) Future Market Insights: 3rd Floor, 207 Regent Street, London W1B 3HH T: +44 20 7692 8790 | D: +44 20 3287 4268 Email: hari.t@futuremarketinsights.com Future Market Insights Global & Consulting Private Limited (FMI) Thank You www.futuremarketinsights.com I @futuremarketins I /company/future-market-insights 10 © 2019 Future Market Insights, All Rights Reserved